The shift in the molecular profile of CRC that develops post-HRT differs between cohorts but a case-control study that stratified patients by age noted female patients age 71 or greater who had previously been on HRT saw the greatest reductions in CRC incidence specifically for microsatellite unstable and/or BRAF mutant disease (36, 37). The gene discussed is BRAF; the disease is colorectal carcinoma.